[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options]

Area of Science:

• Internal Medicine
• Hematology
• Allergy and Immunology

Background:

• Systemic mast cell activation disease (SMACD) presents complex clinical phenotypes.
• Understanding pathogenetic relationships is crucial for accurate diagnosis and treatment.
• Current therapeutic concepts for SMACD require comprehensive review.

Observation:

• SMACD should be considered early in patients with chronic multisystem polymorbidity.
• Recognizing clinical phenotypes aids in early disease identification.
• Minimally invasive investigations are key for diagnosing SMACD.

Findings:

• Specific diagnostic algorithms facilitate SMACD identification.
• Personalized drug therapy can be effectively counseled based on diagnosis.
• Early diagnosis allows for timely initiation of appropriate treatment.

Implications:

• Integrating SMACD into differential diagnoses improves patient management.
• Enhanced diagnostic approaches lead to more effective therapeutic strategies.
• This review provides a framework for clinicians to manage SMACD effectively.